KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2025)

Historic Cash from Restructuring for Hims & Hers Health (HIMS) over the last 3 years, with Q3 2025 value amounting to $2.0 million.

  • Hims & Hers Health's Cash from Restructuring changed N/A to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 106182.67%. This contributed to the annual value of $2.7 million for FY2023, which is 22150.54% up from last year.
  • According to the latest figures from Q3 2025, Hims & Hers Health's Cash from Restructuring is $2.0 million.
  • Hims & Hers Health's 5-year Cash from Restructuring high stood at $2.0 million for Q3 2025, and its period low was -$256000.0 during Q3 2022.
  • Moreover, its 3-year median value for Cash from Restructuring was $566000.0 (2023), whereas its average is $771727.3.
  • Examining YoY changes over the last 5 years, Hims & Hers Health's Cash from Restructuring showed a top increase of 464545.45% in 2023 and a maximum decrease of 5874.4% in 2023.
  • Quarter analysis of 3 years shows Hims & Hers Health's Cash from Restructuring stood at $1.0 million in 2022, then crashed by 58.74% to $427000.0 in 2023, then surged by 362.76% to $2.0 million in 2025.
  • Its Cash from Restructuring stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.0 million for Q1 2025.